AU7398300A - Chlamydia antigens and corresponding dna fragments and uses thereof - Google Patents
Chlamydia antigens and corresponding dna fragments and uses thereofInfo
- Publication number
- AU7398300A AU7398300A AU73983/00A AU7398300A AU7398300A AU 7398300 A AU7398300 A AU 7398300A AU 73983/00 A AU73983/00 A AU 73983/00A AU 7398300 A AU7398300 A AU 7398300A AU 7398300 A AU7398300 A AU 7398300A
- Authority
- AU
- Australia
- Prior art keywords
- dna fragments
- corresponding dna
- chlamydia antigens
- chlamydia
- antigens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000606161 Chlamydia Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15432599P | 1999-09-17 | 1999-09-17 | |
US60/154325 | 1999-09-17 | ||
PCT/CA2000/001086 WO2001021802A1 (en) | 1999-09-17 | 2000-09-15 | Chlamydia antigens and corresponding dna fragments and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7398300A true AU7398300A (en) | 2001-04-24 |
Family
ID=22550898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU73983/00A Abandoned AU7398300A (en) | 1999-09-17 | 2000-09-15 | Chlamydia antigens and corresponding dna fragments and uses thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7398300A (en) |
WO (1) | WO2001021802A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9814878A (en) * | 1997-11-21 | 2000-10-03 | Genset Sa | Genetic sequence and polypeptides of chlamydia pneumoniae, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
JP2002517179A (en) * | 1997-11-28 | 2002-06-18 | ジェンセット | Chlamydiatrachomatis genomic sequences and polypeptides, fragments thereof, and their use especially for the diagnosis, prevention and treatment of infectious diseases |
-
2000
- 2000-09-15 AU AU73983/00A patent/AU7398300A/en not_active Abandoned
- 2000-09-15 WO PCT/CA2000/001086 patent/WO2001021802A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001021802A1 (en) | 2001-03-29 |
WO2001021802B1 (en) | 2001-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7398200A (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
AU3760100A (en) | Immunostimulatory nucleic acids and antigens | |
AU2001287430A1 (en) | Moraxella polypeptides and corresponding dna fragments and uses thereof | |
AU8173098A (en) | Neuroprotective methods and reagents | |
AU2138501A (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
AU2001248172A1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
AU2001248176A1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
AU2001248171A1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
AU3072500A (en) | Rhamnosyl-transferase gene and uses thereof | |
AU5245900A (en) | Novel protein and dna thereof | |
AU2138601A (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
AU2001248178A1 (en) | Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof | |
EP2088197B8 (en) | Haemophilus influenzae antigens and corresponding DNA fragments | |
AU2001274566A1 (en) | Novel protein and dna thereof | |
AU1891301A (en) | Novel polypeptide and dna thereof | |
AU2001285155A1 (en) | Polymorphic dna fragments and uses thereof | |
AU1375501A (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
AU2002216863A1 (en) | Streptococcus pyogenes antigens and corresponding DNA fragments | |
AU5617200A (en) | Nodavirus-based dna expression vector and uses thereof | |
AU5668500A (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
AU7398400A (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
AU7398300A (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
AU7398700A (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
AU7398600A (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
AU1375601A (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |